Group A: Children thru Adolescent (Age 13 thru 18) with Developmental Disorders (LD, ADHD, Autism etc). Group B: Geriatric Adults (Age 65 thru 100) with Dementia. Control Group (vs Groups A,B): Adolescent thru Geriatric age, basically those who do not meet criterias A and B, who are capable of leading a normal active daily life compared with the same Groups A, B.
Conditions
Interventions
Pet dog for 5 minutes, walk dog for with double lead for 5 minutes, and conduct a reading program (reading picture books to the dog) for 5 minutes, repeating this every two weeks, for a total of 6 tim
Sponsors
Asahikawa Medical University
Midorinomori Animal Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Group A: Using the Ministry of Education, Culture, Sports, Science and Technology standards, minors (aged 13 to under 18) who face barriers such as Learning Disorder (LD), Attention Deficit/Hyperactivity Disorder (ADHD), high-functioning autism, developmental coordination disorder, social withdrawal, and long-term absenteeism, who find it difficult to lead a typical social life. Group B: Elderly individuals (aged 65 to under 100) who have some form of dementia (including multi-infarct dementia, Alzheimer's type dementia, and Lewy body dementia) or mental and neurological symptoms such as geriatric depression, making it difficult for them to lead a normal social life. Control group ("control" vs. groups A and B): Patients without serious cardiopulmonary dysfunction necessitating drug therapy or neuropsychiatric disorders,who are deemed appropriate by the attending physician (aged 18 to under 100). This group can be compared to groups A and B and is characterized as being able to "live a social life."
Exclusion criteria
Exclusion criteria: 1)Patients with cognitive dysfunction due to high-order brain function disorders caused by traffic trauma, brain tumors, or metastasis of cancer to the brain. 2)Patients with a clear history of dog allergies or phobias who cannot withstand treatment involving contact with dogs for about 30 minutes. 3)Patients who have participated in similar treatment studies within the past 12 weeks. 4)Patients who have previously exhibited inhumane violent behavior towards animals. 5)Other patients deemed inappropriate for participation by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To see if mental evaluated items; 'motivation' and 'spontaneity' improve as main evaluation outcome(s). | — |
Secondary
| Measure | Time frame |
|---|---|
| To see if physical parameters, cognitive function, and autonomic nervous system parameters (using HRV data) improve as secondary evaluation outcome(s). | — |
Countries
Japan
Contacts
Public ContactOu Oikawa
Asahikawa Medical University Hospital Department of Rehabilitation Medicine
Outcome results
None listed